Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of General Virology

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/VIR.0.82172-0PMID 17030866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blockade of the Poliovirus-Induced Cytopathic Effect in Neural Cells by Monoclonal Antibody against Poliovirus or the Human Poliovirus Receptor

  2005cited by this paper
• Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene—influence of the transgene expression on pathogenesis

  2005cited by this paper
• An Authentic 3′ Noncoding Region Is Necessary for Efficient Poliovirus Replication

  2005cited by this paper
• Mutation of a Single Conserved Nucleotide between the Cloverleaf and Internal Ribosome Entry Site Attenuates Poliovirus Neurovirulence

  2005cited by this paper
• Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys.

  2005cited by this paper
• Genetic Determinants of Cell Type-Specific Poliovirus Propagation in HEK 293 Cells

  2005cited by this paper
• Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation.

  2005cited by this paper
• Variability in apoptotic response to poliovirus infection.

  2005cited by this paper
• Nogo-A, -B, and -C Are Found on the Cell Surface and Interact Together in Many Different Cell Types*

  2005cited by this paper
• Poliovirus replication and spread in primary neuron cultures.

  2005cited by this paper
• A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice.

  2004cited by this paper
• Characterization of in vitro and in vivo phenotypes of poliovirus type 1 mutants with reduced viral protein synthesis activity.

  2004cited by this paper
• A Novel Approach for Producing Lentiviruses That Are Limited to a Single Cycle of Infection

  2004cited by this paper
• Comparison of neuropathogenicity of poliovirus in two transgenic mouse strains expressing human poliovirus receptor with different distribution patterns.

  2002cited by this paper
• An ex vivo murine model to study poliovirus-induced apoptosis in nerve cells.

  2002cited by this paper
• Immunofluorescence Technique Using HeLa Cells Expressing Recombinant Nucleoprotein for Detection of Immunoglobulin G Antibodies to Crimean-Congo Hemorrhagic Fever Virus

  2002cited by this paper
• Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection.

  2002cited by this paper
• Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells

  2002cited by this paper
• Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71

  2002cited by this paper
• Application of an automated specimen search system installed in a transmission electron microscope for the detection of caliciviruses in clinical specimens.

  2002cited by this paper
• Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys.

  2001cited by this paper
• Repetitive Intrathecal Injections of Poliovirus Replicons Result in Gene Expression in Neurons of the Central Nervous System Without Pathogenesis

  2001cited by this paper
• Targeted foreign gene expression in spinal cord neurons using poliovirus replicons.

  2000cited by this paper
• Isolation and Molecular Characterization of a Poliovirus Type 1 Mutant That Replicates in the Spinal Cords of Mice

  1999cited by this paper
• Poliovirus Induces Apoptosis in the Mouse Central Nervous System

  1999cited by this paper
• Interaction of Poliovirus with Its Receptor Affords a High Level of Infectivity to the Virion in Poliovirus Infections Mediated by the Fc Receptor

  1999cited by this paper
• Encapsidation studies of poliovirus subgenomic replicons.

  1998cited by this paper
• Interaction of Poliovirus with Its Purified Receptor and Conformational Alteration in the Virion

  1998cited by this paper
• trans-Encapsidation of a Poliovirus Replicon by Different Picornavirus Capsid Proteins

  1998cited by this paper
• Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase.

  1998cited by this paper
• Internal Ribosome Entry Sites within the RNA Genomes of Hepatitis C Virus and Other Flaviviruses

  1997cited by this paper
• Persistent poliovirus infection in mouse motoneurons

  1997cited by this paper
• Spinal cord transection--no loss of distal ventral horn neurons. Modern stereological techniques reveal no transneuronal changes in the ventral horns of the mouse lumbar spinal cord after thoracic cord transection.

  1997cited by this paper
• Attenuating mutations in the poliovirus 5' untranslated region alter its interaction with polypyrimidine tract-binding protein

  1997cited by this paper
• Early and late losses of motor units after poliomyelitis.

  1997cited by this paper
• Spinal Cord Transection-No Loss of Distal Ventral Horn Neurons

  1997cited by this paper
• Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating

  1996cited by this paper
• Attenuation stem-loop lesions in the 5' noncoding region of poliovirus RNA: neuronal cell-specific translation defects

  1996cited by this paper
• Final checkpoint in the drug‐promoted and poliovirus‐promoted apoptosis is under post‐translational control by growth factors

  1996cited by this paper
• Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.

  1995cited by this paper
• Production of high-titer helper-free retroviruses by transient transfection.

  1993cited by this paper
• Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans

  1993cited by this paper
• Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice

  1992cited by this paper
• Use of the human elongation factor 1α promoter as a versatile and efficient expression system

  1990cited by this paper
• Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system.

  1990cited by this paper
• Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.

  1990cited by this paper
• In vitro construction of poliovirus defective interfering particles

  1989cited by this paper
• Molecular pathogenesis of neural lesions induced by poliovirus type 1.

  1989cited by this paper
• Construction and characterization of poliovirus subgenomic replicons

  1988cited by this paper
• Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

  1987cited by this paper
• Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

  1986cited by this paper
• The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies.

  1985cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Experimental poliomyelitis following intramuscular virus injection. I. The effect of neural block on a neurotropic and a pantropic strain.

  1961cited by this paper
• Histopathologic basis of clinical findings in poliomyelitis.

  1949cited by this paper
• Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche

  1931cited by this paper

• Enterovirus and Parechovirus Neurologic Infections in Children: Clinical Presentations and Neuropathogenesis.

  2025cites this paper
• An efficient trans complementation system for in vivo replication of defective poliovirus mutants

  2024cites this paper
• Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient

  2024cites this paper
• Construction of an infectious clone for enterovirus A89 and mutagenesis analysis of viral infection and cell binding

  2024cites this paper
• Characterization of Anti-Poliovirus Compounds Isolated from Edible Plants

  2023cites this paper
• High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test

  2022cites this paper
• Essential Domains of Oxysterol-Binding Protein Required for Poliovirus Replication

  2022cites this paper
• Comparison of the neutralizing activities of antibodies in clinical sera against both Sabin and wild-type polio pseudoviruses.

  2021cites this paper
• High-Order Epistasis and Functional Coupling of Infection Steps Drive Virus Evolution toward Independence from a Host Pathway

  2021cites this paper
• A novel orally infected hamster model for Coxsackievirus A16 hand-foot-and-mouth disease and encephalomyelitis

  2020cites this paper
• Enterovirus and Encephalitis

  2020cites this paper
• Coxsackievirus A16 in a 1-Day-Old Mouse Model of Central Nervous System Infection Shows Lower Neurovirulence than Enterovirus A71.

  2020cites this paper
• Myristoylation of EV71 VP4 is Essential for Infectivity and Interaction with Membrane Structure

  2020cites this paper
• Characterization of a new anti-enterovirus 68 compound purified from avocado.

  2020cites this paper
• Evaluation of antigenic differences between wild and Sabin vaccine strains of poliovirus using the pseudovirus neutralization test

  2019cites this paper
• A Novel Neutralizing Antibody Specific to the DE Loop of VP1 Can Inhibit EV-D68 Infection in Mice

  2018cites this paper
• microRNA expression profiling in human diploid cells infected with enterovirus 71 or coxsackievirus A 16

  2018cites this paper
• A safe and reliable neutralization assay based on pseudovirus to measure neutralizing antibody titer against poliovirus

  2017cites this paper
• Poliovirus Studies during the Endgame of the Polio Eradication Program.

  2017cites this paper
• Allosteric Regulation of Phosphatidylinositol 4-Kinase III Beta by an Antipicornavirus Compound MDL-860.

  2017cites this paper
• Mechanism of Poliovirus Resistance to Host Phosphatidylinositol-4 Kinase III β Inhibitor.

  2016cites this paper
• Phosphatidylinositol 4‐kinase III beta is the target of oxoglaucine and pachypodol (Ro 09‐0179) for their anti‐poliovirus activities, and is located at upstream of the target step of brefeldin A

  2015cites this paper
• Pathological findings in a mouse model for Coxsackievirus A16 infection

  2015cites this paper
• Enterovirus D68 Infection

  2015cites this paper
• Development of a novel single step reverse genetics system for feline calicivirus.

  2014cites this paper
• Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.

  2014cites this paper
• Novel enterovirus inhibitors; Viral and host targets

  2014cites this paper
• Compoundsof Minor Enviroxime-Like Oxysterol-Binding Protein Family I Is the

  2014cites this paper
• Soluble Poliovirus Receptor Magnetic Nanoparticles Sensitized with Method from Stool Extracts by Using Development of Poliovirus Extraction

  2014cites this paper
• SUPPLEMENTAL INFORMATION TO: Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein (OSBP)

  2014cites this paper
• Experimental infection of tree shrews (Tupaia belangeri) with Coxsackie virus A16.

  2014cites this paper
• The Gene Expression Profile of Peripheral Blood Mononuclear Cells from EV71-Infected Rhesus Infants and the Significance in Viral Pathogenesis

  2014cites this paper
• Coxsackievirus A 16 infection does not interfere with the specific immune response induced by an enterovirus 71 inactivated vaccine in rhesus monkeys.

  2014cites this paper
• Oxysterol-Binding Protein Family I Is the Target of Minor Enviroxime-Like Compounds

  2013cites this paper
• [Exploration for anti-enterovirus compounds and analysis on the mechanism of its inhibitory effect on virus infection].

  2013cites this paper
• Antipoliovirus Activity Target of Enviroxime-Like Compounds for Phosphatidylinositol 4-Kinase III Beta Is a

  2013cites this paper
• Development of Poliovirus Extraction Method from Stool Extracts by Using Magnetic Nanoparticles Sensitized with Soluble Poliovirus Receptor

  2013cites this paper
• The effect of enterovirus 71 immunization on neuropathogenesis and protein expression profiles in the thalamus of infected rhesus neonates.

  2012cites this paper
• Valosin-Containing Protein (VCP/p97) Is Required for Poliovirus Replication and Is Involved in Cellular Protein Secretion Pathway in Poliovirus Infection

  2012cites this paper
• ACBD3‐mediated recruitment of PI4KB to picornavirus RNA replication sites

  2011cites this paper
• Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human Serum

  2011cites this paper
• Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection.

  2011cites this paper
• Introduction of a strong temperature-sensitive phenotype into enterovirus 71 by altering an amino acid of virus 3D polymerase.

  2010cites this paper
• Phosphatidylinositol 4-Kinase III Beta Is a Target of Enviroxime-Like Compounds for Antipoliovirus Activity

  2010cites this paper
• A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection.

  2010cites this paper
• Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime.

  2009cites this paper
• Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity.

  2008cites this paper
• Cooperative Effect of the Attenuation Determinants Derived from Poliovirus Sabin 1 Strain Is Essential for Attenuation of Enterovirus 71 in the NOD/SCID Mouse Infection Model

  2007influential citation
• An Attenuated Strain of Enterovirus 71 Belonging to Genotype A Showed a Broad Spectrum of Antigenicity with Attenuated Neurovirulence in Cynomolgus Monkeys

  2007cites this paper